Darlington
Oral bisphosphonates: reminder of precautions to take
All bisphosphonates are associated with a risk of osteonecrosis of the jaw (ONJ). Therefore before prescribing oral bisphosphonates, we remind you to tell patients to maintain good oral hygiene, attend routine dental check-ups and immediately report any oral symptoms such as dental mobility, pain, or swelling to a doctor and dentist.
Paracetamol administration with Meningococcal B (Men B) vaccine
On September 1st the new national Meningococcal B (Men B) immunisation programme for infants began. As administration of Men B vaccine when given with other routine primary vaccines often produces a fever, Public Health England recommend that infants are given a 60mg prophylactic dose of paracetamol at the time or soon after vaccination plus two further doses at intervals of 4-6 hours. The advice from PHE is clear that parents / carers are responsible for obtaining and administering the paracetamol and it should not be prescribed.
Bulletin – Controlled Drugs: Learning from Incidents
Controlled Drugs: Learning from Incidents July 2015 NECS supports the NHS England Area Team Controlled Drugs Accountable Officer in ensuring […]
July 2015 out of stock information
Antepsin – Supply Difficulties (Chugai) – Chugai has advised that there is no stock for community pharmacies of both Antepsin […]
APC update July 2015
The following guidelines have been approved and are now available for use in Durham and Darlington CCGs: Oral analgesia in […]
Nalmefene and Psychosocial Support in County Durham – update
In December 2014 a prescribing memo advised that NICE guidance had been issued for nalmefene in alcohol dependence, and emphasized […]
Prescribing reminder – Subcutaneous methotrexate
Across Darlington, DDES and North Durham CCGs a small number of rheumatology patients who are unsuitable for oral methotrexate are […]
Nalmefene and Psychosocial Support
Nalmefene was recommended for use in “NICE technology appraisal guidance 235: Nalmefene for reducing alcohol consumption in people with alcohol […]
Adrenaline auto-injectors: advice on use from MHRA
In May 2014 the MHRA issued guidance on the use of adrenaline auto-injectors, with the following key messages for patients; […]